Cargando…

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia

Detalles Bibliográficos
Autores principales:	McGowan, Mary P., Hosseini Dehkordi, Seyed Hamed, Moriarty, Patrick M., Duell, P. Barton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951065/ https://www.ncbi.nlm.nih.gov/pubmed/31838973 http://dx.doi.org/10.1161/JAHA.119.013225

Ejemplares similares

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children
por: Sonnett, Travis, et al.
Publicado: (2010)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
por: Agarwala, Anandita, et al.
Publicado: (2021)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
por: Catapano, Alberico Luigi, et al.
Publicado: (2017)

Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
por: Shmueli, Hezzy, et al.
Publicado: (2020)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
por: Ershova, Alexandra I., et al.
Publicado: (2016)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
por: Peterson, Amy L., et al.
Publicado: (2021)

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2012)

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
por: Kataoka, Yu, et al.
Publicado: (2022)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021)

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
por: Marco-Benedí, Victoria, et al.
Publicado: (2021)

Awareness and knowledge of heterozygous familial hypercholesterolemia among Serbian pediatricians
por: Bjelakovic, Ljiljana, et al.
Publicado: (2023)

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters
por: Vuorio, Alpo, et al.
Publicado: (2018)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
por: Cuchel, Marina, et al.
Publicado: (2023)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
por: Bhatti, Navdeep K., et al.
Publicado: (2016)

Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis
por: Addison, Daniel, et al.
Publicado: (2021)

Defining a Mobile Health Roadmap for Cardiovascular Health and Disease
por: Eapen, Zubin J., et al.
Publicado: (2016)

Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial Hypercholesterolemia
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2020)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model
por: McGowan, Mary P., et al.
Publicado: (2021)

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
por: Moriarty, Patrick M., et al.
Publicado: (2016)

Review of the NAEPP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines
por: Urbano, Frank L.
Publicado: (2008)

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
por: Ginsberg, Henry N., et al.
Publicado: (2019)

Molecular diagnosis methods in familial hypercholesterolemia
por: Moldovan, Valeriu, et al.
Publicado: (2020)

Whole Exome Sequencing Insufficient for a Definitive Diagnosis of a Patient with Compound Heterozygous Familial Hypercholesterolemia
por: Okada, Hirofumi, et al.
Publicado: (2022)

US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future
por: Kovell, Lara C., et al.
Publicado: (2015)

Delirium in the Cardiac Intensive Care Unit
por: Ibrahim, Khalil, et al.
Publicado: (2018)

Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?
por: Folsom, Aaron R., et al.
Publicado: (2020)

Physical Activity in the Prevention and Treatment of Coronary Artery Disease
por: Winzer, Ephraim Bernhard, et al.
Publicado: (2018)

Cumulative Lifetime Burden of Cardiovascular Disease From Early Exposure to Air Pollution
por: Kim, Juyong Brian, et al.
Publicado: (2020)

Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies
por: Roy, Gabrielle, et al.
Publicado: (2021)

Using Mobile Technology for Cardiac Rehabilitation: A Review and Framework for Development and Evaluation
por: Beatty, Alexis L., et al.
Publicado: (2013)

Choice and Selection of Treatment Modalities for Cardiac Patients: An Interventional Cardiology Perspective
por: Agarwal, Shikhar, et al.
Publicado: (2015)

Impact, role, and contribution of family in the mental health of industrial workers
por: Avasthi, Ajit, et al.
Publicado: (2021)

Evidence That a Subset of Aneurysms Less Than 7 mm Warrant Treatment
por: Zanaty, Mario, et al.
Publicado: (2016)

Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
por: Prins, Kurt W., et al.
Publicado: (2018)

Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications
por: Tzamaloukas, Antonios H., et al.
Publicado: (2019)

Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
por: Lteif, Christelle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7dm7n7p1aojmebk9r4b10il63i